A study in solid organ transplant recipients shows oral therapy for gram-negative bacteremia may not need to be restricted to immunocompetent individuals.
Read More
Match Day is a highly anticipated event where graduating medical students find out where they will complete their residency training. How did 2024 measure up?
Read More
The Cardior acquisition may revolutionize the management and treatment of cardiovascular disease, ultimately benefiting both physicians and patients.
Read More
Some studies suggest a link between celestial events and hormone fluctuations in psychiatric...
Read More
Female carriers of choroideremia and X-linked retinitis pigmentosa have significantly worse visual symptoms across seven domains compared with healthy patients.
Read More
While health care and societal costs are routinely modelled for most diseases, there’s a lack of comprehensive data and cost-of-illness studies for IRDs.
Read More
Researchers compared the sensitivity of an elastic-scattering spectroscopy device versus dermatologist examinations for detecting skin lesions.
Read More
Researchers examined why patients who experience seizures may also face a higher degree of vascular disease.
Read More
There is significant underdiagnosis and suboptimal clinical management of coconut allergy in the US.
Read More
There is significant underdiagnosis and suboptimal clinical management of coconut allergy in the US.
Read More
Patients had lower blood pressure readings at home, suggesting telemedicine may be a promising resource for improving hypertension management.
Read More
Frailty represents a comprehensive health measure in epilepsy, according to findings published in Epilepsia.
Read More
For patients with epilepsy, having public health insurance and a shorter travel time to an epilepsy center influences receipt of timely surgical treatment.
Read More
Both physicians in training and well-established physicians should stay abreast of healthcare industry trends, as they can significantly impact compensation.
Read More
A recent analysis compared low-dose computed tomography with chest radiography in a sample of patients eligible for the National Lung Screening Trial.
Read More
Phase 2 trial results show reductions in the abscesses and inflammatory nodule count were induced by topical treatment with ruxolitinib versus vehicle.
Read More
Researchers observed consistent response rates through 4 years of bimekizumab therapy in patients with psoriasis from several trials.
Read More
The anti-OX40 antibody amlitelimab showed maintenance of response even after treatment discontinuation in the STREAM-AD study.
Read More
Results from the KNOCKOUT trial show high induction doses of the IL-23 blocker risankizumab led to a marked reduction in resident memory T cells.
Read More
More than 80% of patients with alopecia areata who responded to baricitinib at week 52 maintained their response until week 152 in the BRAVE-AA trials.
Read More
